Autophagy in drug-induced liver toxicity

Journal of Food and Drug Analysis

Volumn 22, Issue 2, 2014, Pages 161-168

  Chen, Si ^a   Melchior, William B ^a   Wu, Yuanfeng ^a   Guo, Lei ^a  

^a NATIONAL CENTER FOR TOXICOLOGICAL RESEARCH   (United States)

Author keywords

Autophagy; Drug induced liver toxicity

Indexed keywords

ALCOHOL; BAFILOMYCIN A1; CHLOROQUINE; EFAVIRENZ; PARACETAMOL; PHOSPHATIDYLINOSITOL 3 KINASE INHIBITOR; PROTEIN P62; RAPAMYCIN; TOXIN; USNIC ACID;

AUTOPHAGOSOME; AUTOPHAGY; DRUG INDUCED DISEASE; DRUG INDUCED LIVER TOXICITY; HUMAN; LIVER TOXICITY; PROTEIN DEGRADATION; REVIEW; STARVATION;

EID: 84914706347     PISSN: 10219498     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jfda.2014.03.007     Document Type: Review

References (82)

1. Ichai P, Samuel D. Epidemiology of liver failure. Clin Res Hepatol Gastroenterol 2011;35:610-7.
2. Lee WM. Drug-induced hepatotoxicity. N Engl J Med 2003;349:474-85.
3. Zhao P, Wang C, Liu W, et al. Causes and outcomes of acute liver failure in China. PLoS One 2013;8. e80991.
4. Suk KT, Kim DJ. Drug-induced liver injury: Present and future. Clin Mol Hepatol 2012;18:249-57.
5. Chen M, Vijay V, Shi Q, et al. FDA-approved drug labeling for the study of drug-induced liver injury. Drug Discov Today 2011;16:697-703.
6. Larson AM, Polson J, Fontana RJ, et al. Acetaminopheninduced acute liver failure: results of a United States multicenter, prospective study. Hepatology 2005;42:1364-72.
7. Kaplowitz N. Drug-induced liver disorders: implications for drug development and regulation. Drug Saf 2001;24:483-90.
8. Senior JR. Drug hepatotoxicity from a regulatory perspective. Clin Liver Dis 2007;11:507-24. vi.
9. Gunawan BK, Kaplowitz N. Mechanisms of drug-induced liver disease. Clin Liver Dis 2007;11:459-75. v.
10. Nadanaciva S, Will Y. The role of mitochondrial dysfunction and drug safety. IDrugs 2009;12:706-10.
11. Nadanaciva S, Will Y. Current concepts in drug-induced mitochondrial toxicity. Curr Protoc Toxicol; 2009. Chapter 2:Unit 2.15.
12. Russmann S, Kullak-Ublick GA, Grattagliano I. Current concepts of mechanisms in drug-induced hepatotoxicity. Curr Med Chem 2009;16:3041-53.
13. Kaplowitz N. Mechanisms of cell death and relevance to drug hepatotoxicity. In: Drug-induced liver disease. Zug, Switzerland: Informa Healthcare; 2007. pp. 85-95. ISBN-13: 978-0-8439-9896-4.
14. Debnath J, Baehrecke EH, Kroemer G. Does autophagy contribute to cell death? Autophagy 2005;1:66-74.
15. Kroemer G, Marino G, Levine B. Autophagy and the integrated stress response. Mol Cell 2010;40:280-93.
16. Vandenabeele P, Galluzzi L, Vanden Berghe T, Kroemer G. Molecular mechanisms of necroptosis: An ordered cellular explosion. Nat Rev Mol Cell Biol 2010;11:700-14.
17. Park EJ, Lee AY, Park S, et al. Multiple pathways are involved in palmitic acid-induced toxicity. Food Chem Toxicol 2014;67:26-34.
18. Roychowdhury S, McMullen MR, Pisano SG, et al. Absence of receptor interacting protein kinase 3 prevents ethanolinduced liver injury. Hepatology 2013;57:1773-83.
19. Zhang YF, He W, Zhang C, et al. Role of receptor interacting protein (RIP)1 on apoptosis-inducing factor-mediated necroptosis during acetaminophen-evoked acute liver failure in mice. Toxicol Lett 2014;225:445-53.
20. Kensler TW, Wakabayashi N, Biswal S. Cell survival responses to environmental stresses via the Keap1-Nrf2-ARE pathway. Annu Rev Pharmacol Toxicol 2007;47:89-116.
21. Ramos-Gomez M, Kwak MK, Dolan PM, et al. Sensitivity to carcinogenesis is increased and chemoprotective efficacy of enzyme inducers is lost in nrf2 transcription factor-deficient mice. Proc Natl Acad Sci U S A 2001;98:3410-5.
22. Walter P, Ron D. The unfolded protein response: from stress pathway to homeostatic regulation. Science 2011;334:1081-6.
23. Wu J, Kaufman RJ. From acute ER stress to physiological roles of the Unfolded Protein Response. Cell Death Differ 2006;13:374-84.
24. Xu C, Bailly-Maitre B, Reed JC. Endoplasmic reticulum stress: cell life and death decisions. J Clin Invest 2005;115:2656-64.
25. Chen S, Xuan J, Wan L, et al. Sertraline, an antidepressant, induces apoptosis in hepatic cells through the mitogenactivated protein kinase pathway. Toxicol Sci 2014;137:404-15.
26. Dara L, Ji C, Kaplowitz N. The contribution of endoplasmic reticulum stress to liver diseases. Hepatology 2011;53:1752-63.
27. Kaplowitz N, Than TA, Shinohara M, et al. Endoplasmic reticulum stress and liver injury. Semin Liver Dis 2007;27:367-77.
28. Malhi H, Kaufman RJ. Endoplasmic reticulum stress in liver disease. J Hepatol 2011;54:795-809.
29. Kroemer G, Levine B. Autophagic cell death: The story of a misnomer. Nat Rev Mol Cell Biol 2008;9:1004-10.
30. Levine B, Kroemer G. Autophagy in the pathogenesis of disease. Cell 2008;132:27-42.
31. Ashford TP, Porter KR. Cytoplasmic components in hepatic cell lysosomes. J Cell Biol 1962;12:198-202.
32. Klionsky DJ. Autophagy revisited: A conversation with Christian de Duve. Autophagy 2008;4:740-3.
33. Pyo JO, Nah J, Jung YK. Molecules and their functions in autophagy. Exp Mol Med 2012;44:73-80.
34. Klionsky DJ. The molecular machinery of autophagy: unanswered questions. J Cell Sci 2005;118(Pt 1):7-18.
35. Klionsky DJ, Emr SD. Autophagy as a regulated pathway of cellular degradation. Science 2000;290:1717-21.
36. Mizushima N, Levine B, Cuervo AM, et al. Autophagy fights disease through cellular self-digestion. Nature 2008;451:1069-75.
37. Yorimitsu T, Nair U, Yang Z, et al. Endoplasmic reticulum stress triggers autophagy. J Biol Chem 2006;281:30299-304.
38. Levine B, Yuan J. Autophagy in cell death: An innocent convict? J Clin Invest 2005;115:2679-88.
39. Williams A, Jahreiss L, Sarkar S, et al. Aggregate-prone proteins are cleared from the cytosol by autophagy: Therapeutic implications. Curr Top Dev Biol 2006;76:89-101.
40. Kuma A, Hatano M, Matsui M, et al. The role of autophagy during the early neonatal starvation period. Nature 2004;432:1032-6.
41. Czaja MJ, Ding WX, Donohue Jr TM, et al. Functions of autophagy in normal and diseased liver. Autophagy 2013;9:1131-58.
42. Klionsky DJ. Guidelines for the use and interpretation of assays for monitoring autophagy. Autophagy 2012;8:445-544.
43. Klionsky DJ, Cuervo AM, Seglen PO. Methods for monitoring autophagy from yeast to human. Autophagy 2007;3:181-206.
44. Mizushima N. Methods for monitoring autophagy. Int J Biochem Cell Biol 2004;36:2491-502.
45. Mizushima N, Yoshimori T, Levine B. Methods in mammalian autophagy research. Cell 2010;140:313-26.
46. Kabeya Y, Mizushima N, Ueno T, et al. LC3, a mammalian homologue of yeast Apg8p, is localized in autophagosome membranes after processing. EMBO J 2000;19:5720-8.
47. Quintart J, Leroy-Houyet MA, Trouet A, et al. Endocytosis and chloroquine accumulation during the cell cycle of hepatoma cells in culture. J Cell Biol 1979;82:644-53.
48. McSheehy PM, Troy H, Kelland LR, et al. Increased tumour extracellular pH induced by Bafilomycin A1 inhibits tumour growth and mitosis in vivo and alters 5- fluorouracil pharmacokinetics. Eur J Cancer 2003;39:532-40.
49. Mitka M. FDA asks physicians to stop prescribing high-dose acetaminophen products. JAMA 2014;311:563.
50. James LP, Mayeux PR, Hinson JA. Acetaminophen-induced hepatotoxicity. Drug Metab Dispos 2003;31:1499-506.
51. Uzi D, Barda L, Scaiewicz V, et al. CHOP is a critical regulator of acetaminophen-induced hepatotoxicity. J Hepatol 2013;59:495-503.
52. Igusa Y, Yamashina S, Izumi K, et al. Loss of autophagy promotes murine acetaminophen hepatotoxicity. J Gastroenterol 2012;47:433-43.
53. Ni HM, Bockus A, Boggess N, et al. Activation of autophagy protects against acetaminophen-induced hepatotoxicity. Hepatology 2012;55:222-32.
54. Ni HM, Boggess N, McGill MR, et al. Liver-specific loss of Atg5 causes persistent activation of Nrf2 and protects against acetaminophen-induced liver injury. Toxicol Sci 2012;127:438-50.
55. Jaeschke H, McGill MR, Ramachandran A. Oxidant stress, mitochondria, and cell death mechanisms in drug-induced liver injury: lessons learned from acetaminophen hepatotoxicity. Drug Metab Rev 2012 Feb;44(1):88-106.
56. Tashima KT, Bausserman L, Alt EN, et al. Lipid changes in patients initiating efavirenz- And indinavir-based antiretroviral regimens. HIV Clin Trials 2003;4:29-36.
57. Jones M, Nunez M. Liver toxicity of antiretroviral drugs. Semin Liver Dis 2012;32:167-76.
58. Loko MA, Bani-Sadr F, Winnock M, et al. Impact of HAART exposure and associated lipodystrophy on advanced liver fibrosis in HIV/HCV-coinfected patients. J Viral Hepat 2011;18:307-14.
59. Apostolova N, Gomez-Sucerquia LJ, Gortat A, et al. Compromising mitochondrial function with the antiretroviral drug efavirenz induces cell survival-promoting autophagy. Hepatology 2011;54:1009-19.
60. Bumpus NN. Efavirenz and 8-hydroxyefavirenz induce cell death via a JNK- And BimEL-dependent mechanism in primary human hepatocytes. Toxicol Appl Pharmacol 2011;257:227-34.
61. Apostolova N, Gomez-Sucerquia LJ, Moran A, et al. Enhanced oxidative stress and increased mitochondrial mass during efavirenz-induced apoptosis in human hepatic cells. Br J Pharmacol 2010;160:2069-84.
62. Apostolova N, Gomez-Sucerquia LJ, Gortat A, et al. Autophagy as a rescue mechanism in efavirenz-induced mitochondrial dysfunction: A lesson from hepatic cells. Autophagy 2011;7:1402-4.
63. Guo L, Shi Q, Fang JL, et al. Review of usnic acid and Usnea barbata toxicity. J Environ Sci Health C Environ Carcinog Ecotoxicol Rev 2008;26:317-38.
64. Ingolfsdottir K. Usnic acid. Phytochemistry 2002;61:729-36.
65. Durazo FA, Lassman C, Han SH, et al. Fulminant liver failure due to usnic acid for weight loss. Am J Gastroenterol 2004;99:950-2.
66. Favreau JT, Ryu ML, Braunstein G, et al. Severe hepatotoxicity associated with the dietary supplement LipoKinetix. Ann Intern Med 2002;136:590-5.
67. Pramyothin P, Janthasoot W, Pongnimitprasert N, et al. Hepatotoxic effect of ()usnic acid from Usnea siamensis Wainio in rats, isolated rat hepatocytes and isolated rat liver mitochondria. J Ethnopharmacol 2004;90:381-7.
68. Yellapu RK, Mittal V, Grewal P, et al. Acute liver failure caused by 'fat burners' and dietary supplements: A case report and literature review. Can J Gastroenterol 2011;25:157-60.
69. Han D, Matsumaru K, Rettori D, et al. Usnic acid-induced necrosis of cultured mouse hepatocytes: inhibition of mitochondrial function and oxidative stress. Biochem Pharmacol 2004;67:439-51.
70. Liu Q, Zhao X, Lu X, et al. Proteomic study on usnic-acidinduced hepatotoxicity in rats. J Agric Food Chem 2012;60:7312-7.
71. Sahu SC, Amankwa-Sakyi M, O'Donnell Jr MW, et al. Effects of usnic acid exposure on human hepatoblastoma HepG2 cells in culture. J Appl Toxicol 2012;32:722-30.
72. Sahu SC, O'Donnell Jr MW, Sprando RL. Interactive toxicity of usnic acid and lipopolysaccharides in human liver HepG2 cells. J Appl Toxicol 2012;32:739-49.
73. Sonko BJ, Schmitt TC, Guo L, et al. Assessment of usnic acid toxicity in rat primary hepatocytes using (1)(3)C isotopomer distribution analysis of lactate, glutamate and glucose. Food Chem Toxicol 2011;49:2968-74.
74. Massey VL, Arteel GE. Acute alcohol-induced liver injury. Front Physiol 2012;3:193.
75. Bailey SM, Cunningham CC. Contribution of mitochondria to oxidative stress associated with alcoholic liver disease. Free Radic Biol Med 2002;32:11-6.
76. Donohue Jr TM. Alcohol-induced steatosis in liver cells. World J Gastroenterol 2007;13:4974-8.
77. Ding WX, Li M, Chen X, et al. Autophagy reduces acute ethanol-induced hepatotoxicity and steatosis in mice. Gastroenterology 2010;139:1740-52.
78. Wu D, Cederbaum AI. Inhibition of autophagy promotes CYP2E1-dependent toxicity in HepG2 cells via elevated oxidative stress, mitochondria dysfunction and activation of p38 and JNK MAPK. Redox Biol 2013;1:552-65.
79. Wu D, Wang X, Zhou R, et al. Alcohol steatosis and cytotoxicity: The role of cytochrome P4502E1 and autophagy. Free Radic Biol Med 2012;53:1346-57.
80. Chen S, Wan L, Couch L, et al. Mechanism study of goldenseal-associated DNA damage. Toxicol Lett 2013;221:64-72.
81. Fu PP, Xia Q, Guo L, et al. Toxicity of kava kava. J Environ Sci Health C Environ Carcinog Ecotoxicol Rev 2008;26:89-112.
82. Guo L, Fuscoe J, Fu P, Mei N. Application of DNA microarray in studies of herbal dietary supplements. In: Casciano DA, Sahu SC, editors. Handbook of systems toxicology. Chichester, UK: John Wiley & Sons, Ltd; 2010. pp. 407-18.